Douglas Lind

No open positions remaining

66 year

Health Technology

Finance

Consumer Services

Profile

Douglas D.
Lind is currently Chief Executive Officer at Apik Bio LLC since 2026.
Dr. Lind is also Co-President & Director at TMune Therapeutics, Inc., Director at HyperMed Imaging, Inc., and Director at Lentigen Technology, Inc. Former roles include Director at Viragen, Inc., MabVax Therapeutics, Inc., Opus Bio, Inc., Strand Life Sciences Pvt Ltd., Spectral Image, Inc., Flexible Stenting Solutions, Inc., and Enveric Biosciences, Inc. Dr. Lind was Managing Director at Burrill LLC from 2012 to 2013, Managing Director at GBP Capital, Managing Director at Biomark Capital Management Co. LLC from 2006 to 2025, Analyst at Morgan Stanley & Co. LLC in 2002, and Research Analyst at PaineWebber, Inc. in 1996.
Education includes graduate studies at the University of Iowa.

Douglas Lind active positions

Companies	Position	Start
TMune Therapeutics, Inc. TMune Therapeutics, Inc. BiotechnologyHealth Technology Provides cancer treatment research and technology development services	President	-
HyperMed Imaging, Inc. HyperMed Imaging, Inc. Medical SpecialtiesHealth Technology Manufactures medical imaging device	Director/Board Member	-
Lentigen Technology, Inc. Lentigen Technology, Inc. BiotechnologyHealth Technology Provides biotechnology services	Director/Board Member	-

All active positions of Douglas Lind

Former positions of Douglas Lind

Companies	Position	End
Biomark Capital Management Co. LLC Biomark Capital Management Co. LLC Investment ManagersFinance Biomark Capital invests in companies located in the United States primarily in North America, along with a specific focus in Russia, Taiwan, India and China. The firm targets companies operating in the fields of the therapeutics, medical devices, molecular diagnostics, healthcare delivery and information technology service sectors. It provides financing for early, mid and later stage capital transactions with an investment size of USD 5 - 10 million.	Private Equity Investor	01/01/2025
Burrill LLC Burrill LLC Investment ManagersFinance Burrill invests in companies located in the United States. The firm focuses on a broad range of sectors. It participates in buyout and early-stage transactions.	Private Equity Investor	31/10/2013
Viragen, Inc. Viragen, Inc. BiotechnologyHealth Technology Develops and researches immunological products	Director/Board Member	01/02/2005
Morgan Stanley & Co. LLC Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	24/01/2002
PaineWebber, Inc. PaineWebber, Inc. Investment Banks/BrokersFinance Provides stock brokerage and asset management services	Corporate Officer/Principal	31/12/1996

See the detail of Douglas Lind's experience

Education of Douglas Lind

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Douglas Lind's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	16
Viragen, Inc. Viragen, Inc. BiotechnologyHealth Technology Develops and researches immunological products	Health Technology
MabVax Therapeutics, Inc. MabVax Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Developed and commercialized immunotherapeutics for the treatment of cancer	Health Technology
Morgan Stanley & Co. LLC Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services	Finance
Burrill LLC Burrill LLC Investment ManagersFinance Burrill invests in companies located in the United States. The firm focuses on a broad range of sectors. It participates in buyout and early-stage transactions.	Finance
PaineWebber, Inc. PaineWebber, Inc. Investment Banks/BrokersFinance Provides stock brokerage and asset management services	Finance
University of Iowa University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Opus Bio, Inc. Opus Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures lentiviral gene delivery technologies	Commercial Services
Strand Life Sciences Pvt Ltd. Strand Life Sciences Pvt Ltd. Packaged SoftwareTechnology Services Develops bioinformatics and clinical diagnostic software	Technology Services
GBP Capital GBP Capital Investment ManagersFinance GBP Capital provides venture funding and assistance to early and mid-stage life science companies. They target companies with unique approaches to diagnostics, therapeutics and medical devices. GBP Capital focuses on investing in companies with technologies that leverage and build upon medical breakthroughs, as well as other major developments taking place within the life-sciences industry.	Finance
Spectral Image, Inc. Spectral Image, Inc. Medical SpecialtiesHealth Technology Develops imaging technology for biomedical use	Health Technology
Flexible Stenting Solutions, Inc. Flexible Stenting Solutions, Inc. Medical/Nursing ServicesHealth Services Develops third-generation flexible peripheral arterial, venous, neurovascular and biliary stents	Health Services
TMune Therapeutics, Inc. TMune Therapeutics, Inc. BiotechnologyHealth Technology Provides cancer treatment research and technology development services	Health Technology
HyperMed Imaging, Inc. HyperMed Imaging, Inc. Medical SpecialtiesHealth Technology Manufactures medical imaging device	Health Technology
Biomark Capital Management Co. LLC Biomark Capital Management Co. LLC Investment ManagersFinance Biomark Capital invests in companies located in the United States primarily in North America, along with a specific focus in Russia, Taiwan, India and China. The firm targets companies operating in the fields of the therapeutics, medical devices, molecular diagnostics, healthcare delivery and information technology service sectors. It provides financing for early, mid and later stage capital transactions with an investment size of USD 5 - 10 million.	Finance
Lentigen Technology, Inc. Lentigen Technology, Inc. BiotechnologyHealth Technology Provides biotechnology services	Health Technology
Enveric Biosciences, Inc. Enveric Biosciences, Inc. Pharmaceuticals: OtherHealth Technology Develops cannabinoid medicines and combination therapies	Health Technology